Literature DB >> 23417624

New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population.

P Plans1.   

Abstract

Herd immunity blocks the transmission of measles, mumps and rubella in a population group when the prevalence of positive serologic results (p) is higher than a critical value (p c), known as the herd immunity threshold. A new preventive strategy should be developed in order to achieve the elimination of measles, rubella and mumps in Europe based on the serological assessment of herd immunity levels in different population groups. This strategy could detect population groups without herd immunity (p < p c) and indicate the additional vaccination coverage required in these groups in order to establish herd immunity and prevent outbreaks. The serological assessment of herd immunity levels in Catalonia, Spain, showed that herd immunity had not been established for measles and mumps in schoolchildren (5-9 years of age) and youths/younger adults (15-29 years of age), and that the additional vaccination coverage required to establish herd immunity in these groups was 1-7%. The new preventive strategy should be used to detect priority population groups for preventive and surveillance activities in European countries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417624     DOI: 10.1007/s10096-013-1836-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Confirmed interruption of indigenous measles transmission in Catalonia.

Authors:  L Salleras; A Domínguez; N Torner
Journal:  Euro Surveill       Date:  2001 Jul-Aug

Review 2.  Eradication of vaccine-preventable diseases.

Authors:  A Hinman
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

3.  Measles eradication in the Americas: progress to date.

Authors:  Ciro A de Quadros; Hector Izurieta; Linda Venczel; Peter Carrasco
Journal:  J Infect Dis       Date:  2004-05-01       Impact factor: 5.226

4.  The concept of herd immunity and the design of community-based immunization programmes.

Authors:  R M Anderson
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

5.  Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage.

Authors:  Pedro Plans-Rubió
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

6.  The vaccination coverage required to establish herd immunity against influenza viruses.

Authors:  Pedro Plans-Rubió
Journal:  Prev Med       Date:  2012-03-04       Impact factor: 4.018

7.  Spotlight on measles 2010: measles elimination in Europe - a new commitment to meet the goal by 2015.

Authors:  I Steffens; R Martin; Pl Lopalco
Journal:  Euro Surveill       Date:  2010-12-16

8.  Prevalence of antibodies associated with herd immunity: a new indicator to evaluate the establishment of herd immunity and to decide immunization strategies.

Authors:  Pedro Plans
Journal:  Med Decis Making       Date:  2010-04-16       Impact factor: 2.583

9.  Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.

Authors:  Angela Domínguez; Nuria Torner; Irene Barrabeig; Ariadna Rovira; Cristina Rius; Joan Cayla; Elsa Plasencia; Sofia Minguell; M Rosa Sala; Ana Martínez; Josep Costa; Mar Mosquera; Carmen Cabezas
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

10.  Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J C Watson; S C Hadler; C A Dykewicz; S Reef; L Phillips
Journal:  MMWR Recomm Rep       Date:  1998-05-22
View more
  13 in total

1.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

2.  One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China.

Authors:  Qing Wang; Xiaoping Cheng; Dandan Liu; Changhui Chen; Kaihu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 4.526

3.  Why does measles persist in Europe?

Authors:  P Plans-Rubió
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-26       Impact factor: 5.103

Review 4.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

5.  Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.

Authors:  Gustavo Olivera-Botello; Laurent Coudeville; Karen Fanouillere; Bruno Guy; Laurent Chambonneau; Fernando Noriega; Nicholas Jackson
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

6.  Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.

Authors:  Masaya M Saito; Keisuke Ejima; Ryo Kinoshita; Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2018-03-22       Impact factor: 3.390

7.  Assessing herd immunity against rubella in Japan: a retrospective seroepidemiological analysis of age-dependent transmission dynamics.

Authors:  Ryo Kinoshita; Hiroshi Nishiura
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

8.  Trends in childhood measles vaccination highlight socioeconomic inequalities in Vietnam.

Authors:  Vu Duy Kien; Hoang Van Minh; Kim Bao Giang; Vu Quynh Mai; Ngo Tri Tuan; Mikkel B Quam
Journal:  Int J Public Health       Date:  2016-10-01       Impact factor: 3.380

9.  Seroprevalence of mumps in healthcare workers in South Korea.

Authors:  Sun-Kyung Kim; Jiwon Jung; Sun Hee Kwak; Min Jee Hong; Sung-Han Kim
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31

10.  [How well are patients with inflammatory rheumatic diseases protected against measles?]

Authors:  U Kiltz; A Celik; S Tsiami; X Baraliakos; I Andreica; D Kiefer; B Bühring; J Braun
Journal:  Z Rheumatol       Date:  2020-09-15       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.